CommentThe metabolic syndrome—a new worldwide definition
References (21)
- et al.
The metabolic syndrome
Lancet
(2005) - et al.
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
Lancet
(2005) Studien ueber das Hypertonie-Hyperglyka “mie-Hyperurika” miesyndrom
Zentralblatt fuer Innere Medizin
(1923)Role of insulin resistance in human disease
Diabetes
(1988)- et al.
Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?
Circulation
(2000) - et al.
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
Diabet Med
(1998) - et al.
Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)
Diabet Med
(1999) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)
JAMA
(2001)- et al.
The metabolic syndrome: prevalence in worldwide populations
Endocrinol Metab Clin North Am
(2004) - et al.
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
Diabetes Care
(2004)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2005 Elsevier Ltd. All rights reserved.